(Exact name of registrant as specified in its charter.)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
VistaGen Therapeutics, Inc. (the "Company") today announced that its largest institutional stockholder entered into a 6-month lock-up agreement. Under the agreement, the stockholder and its affiliates agreed not to enter into any transaction involving the Company's securities during the term of the agreement, which runs through late-October 2017 and covers approximately 36% of the Company's issued and outstanding equity securities on an as converted basis. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1, and is incorporated herein by reference.
See Exhibit Index.
VistaGen Therapeutics, Inc. |
By: | /s/ Shawn K. Singh |
Name: Shawn K. Singh | |
Title: Chief Executive Officer |
Exhibit No. | Description | |
EX-99.1 | Press release issued by VistaGen Therapeutics Inc., dated May 1, 2017. |